BCG therapy for bladder cancer

Publish Year: 1397
نوع سند: مقاله کنفرانسی
زبان: English
View: 556

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

MBMED05_023

تاریخ نمایه سازی: 1 دی 1397

Abstract:

Background: BCG therapy is used as a treatment in bladder cancer. Methods: Intravesical administration of Bacillus Calmette-Guérin is used as a treatment method in superficial bladder cancer. While it is commonly effective, some serious side effects may occur. We hereby report a 65-year-old man who developed granulomatous hepatitis as a complication following BCG therapy. Results and Conclution: He was treated successfully with antitubercular therapy and prednisolone.

Authors

Mohsen Ayati

Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran

Mohammad Reza Nowroozi

Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran

Afshin Mortazavi

Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran

Solmaz Ohadian Moghadam

Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran